MAFEIP is a web-based tool whose purpose is to estimate the health and economic outcomes of a large variety of social and technological innovations. From the EIP on AHA perspective, MAFEIP represents the key instrument to estimate the impact of EIP on AHA interventions.
MAFEIP enables early impact assessments of an innovative process in the health and care sector. Using this tool can help decision-makers to take informed decisions about the future design of this innovative process or about its deployment on a larger scale (this is the “decision to invest”).
MAFEIP can also help, at a later stage of the innovation development, to assess precisely its value for citizens and other stakeholders (this is the “decision to buy”).
The potential users of the MAFEIP tool are stakeholders in the health and care sectors who are willing to deploy innovative practices to improve quality of care, better accessibility or more efficient use of resources.
By the end of 2017, a renewed version of the MAFEIP tool will be released. Several improvements and new functionalities will be implemented following the results of the MAFEIP study, carried out by Open Evidence and empirica on the basis of 15 use cases (2015).
In 2018, a new MAFEIP website will be launched and form part of the EIP on AHA portal, with the aim of providing ad hoc support and useful information to the different categories of stakeholders involved in the EIP on AHA as well as potential users from outside the EIP on AHA community.
The MAFEIP team will continue to offer technical and personalised support to the user community, with the goal of helping organisations to take full advantage of the tool in their decision-making processes.
From 2018 up to 2020, regular report of MAFEIP outputs illustrating the impact on the EIP on AHA activities will be released.